These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 20197624

  • 41. Erythrocytosis-associated HIF-2alpha mutations demonstrate a critical role for residues C-terminal to the hydroxylacceptor proline.
    Furlow PW, Percy MJ, Sutherland S, Bierl C, McMullin MF, Master SR, Lappin TR, Lee FS.
    J Biol Chem; 2009 Apr 03; 284(14):9050-8. PubMed ID: 19208626
    [Abstract] [Full Text] [Related]

  • 42. Endothelin-1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia.
    Bushuev VI, Miasnikova GY, Sergueeva AI, Polyakova LA, Okhotin D, Gaskin PR, Debebe Z, Nekhai S, Castro OL, Prchal JT, Gordeuk VR.
    Haematologica; 2006 Jun 03; 91(6):744-9. PubMed ID: 16769575
    [Abstract] [Full Text] [Related]

  • 43. The HIF and other quandaries in VHL disease.
    Tarade D, Ohh M.
    Oncogene; 2018 Jan 11; 37(2):139-147. PubMed ID: 28925400
    [Abstract] [Full Text] [Related]

  • 44. Concurrent heterozygous Von-Hippel-Lindau and transmembrane-protein-127 gene mutation causing an erythropoietin-secreting pheochromocytoma in a normotensive patient with severe erythrocytosis.
    Negro A, Graiani G, Nicoli D, Farnetti E, Casali B, Verzicco I, Tedeschi S, Ghirarduzzi A, Cannone V, Marco LDE, Filice A, Gemelli G, Giunta A, Cabassi A.
    J Hypertens; 2020 Feb 11; 38(2):340-346. PubMed ID: 31568062
    [Abstract] [Full Text] [Related]

  • 45. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
    Gong K, Zhang N, Zhang K, Na Y.
    Int J Mol Med; 2010 Dec 11; 26(6):907-12. PubMed ID: 21042786
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Systemic VHL gene functions and the VHL disease.
    Bader HL, Hsu T.
    FEBS Lett; 2012 Jun 04; 586(11):1562-9. PubMed ID: 22673568
    [Abstract] [Full Text] [Related]

  • 49. Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor α.
    Okumura F, Uematsu K, Byrne SD, Hirano M, Joo-Okumura A, Nishikimi A, Shuin T, Fukui Y, Nakatsukasa K, Kamura T.
    Mol Cell Biol; 2016 Jun 15; 36(12):1803-17. PubMed ID: 27090638
    [Abstract] [Full Text] [Related]

  • 50. A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove.
    Percy MJ, Furlow PW, Beer PA, Lappin TR, McMullin MF, Lee FS.
    Blood; 2007 Sep 15; 110(6):2193-6. PubMed ID: 17579185
    [Abstract] [Full Text] [Related]

  • 51. Action of hypoxia-inducible factor in liver and kidney from mice with Pax8-rtTA-based deletion of von Hippel-Lindau protein.
    Mathia S, Paliege A, Koesters R, Peters H, Neumayer HH, Bachmann S, Rosenberger C.
    Acta Physiol (Oxf); 2013 Mar 15; 207(3):565-76. PubMed ID: 23384425
    [Abstract] [Full Text] [Related]

  • 52. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
    Vortmeyer AO, Falke EA, Gläsker S, Li J, Oldfield EH.
    Acta Neuropathol; 2013 Mar 15; 125(3):333-50. PubMed ID: 23400300
    [Abstract] [Full Text] [Related]

  • 53. Identification of Ror2 as a hypoxia-inducible factor target in von Hippel-Lindau-associated renal cell carcinoma.
    Wright TM, Rathmell WK.
    J Biol Chem; 2010 Apr 23; 285(17):12916-24. PubMed ID: 20185829
    [Abstract] [Full Text] [Related]

  • 54. Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression.
    Gordeuk VR, Miasnikova GY, Sergueeva AI, Niu X, Nouraie M, Okhotin DJ, Polyakova LA, Ammosova T, Nekhai S, Ganz T, Prchal JT.
    Blood; 2011 Nov 10; 118(19):5278-82. PubMed ID: 21876117
    [Abstract] [Full Text] [Related]

  • 55. Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer.
    Lanikova L, Lorenzo F, Yang C, Vankayalapati H, Drachtman R, Divoky V, Prchal JT.
    Blood; 2013 May 09; 121(19):3918-24. PubMed ID: 23538339
    [Abstract] [Full Text] [Related]

  • 56. VHL type 2B mutations retain VBC complex form and function.
    Hacker KE, Lee CM, Rathmell WK.
    PLoS One; 2008 May 09; 3(11):e3801. PubMed ID: 19030229
    [Abstract] [Full Text] [Related]

  • 57. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA, Ashcroft M.
    Cancer Res; 2006 Jun 15; 66(12):6264-70. PubMed ID: 16778202
    [Abstract] [Full Text] [Related]

  • 58. Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.
    Bartels M, van der Zalm MM, van Oirschot BA, Lee FS, Giles RH, Kruip MJ, Gitz-Francois JJ, Van Solinge WW, Bierings M, van Wijk R.
    Hum Mutat; 2015 Nov 15; 36(11):1039-42. PubMed ID: 26224408
    [Abstract] [Full Text] [Related]

  • 59. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade.
    Shah YM, Ito S, Morimura K, Chen C, Yim SH, Haase VH, Gonzalez FJ.
    Gastroenterology; 2008 Jun 15; 134(7):2036-48, 2048.e1-3. PubMed ID: 18439915
    [Abstract] [Full Text] [Related]

  • 60. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.
    Rankin EB, Tomaszewski JE, Haase VH.
    Cancer Res; 2006 Mar 01; 66(5):2576-83. PubMed ID: 16510575
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.